Taiwan FDA registration eb99f1255a4c2c6e24641aeb7d9e94c7

Liyashang EBV Capsid Antigen IgM Detection Reagent - Quality Control Solution

TW: 禮雅尚EB病毒殼抗原IgM檢測試劑-品管液
Taiwan flagTaiwan·Risk Class 2·DIASORIN ITALIA S.P.A.·Registered Sep 22, 2023 – Sep 22, 2028Active
Registration details
Analysis ID
eb99f1255a4c2c6e24641aeb7d9e94c7
Customs Code
DHA05603622308
Company information
Manufacturer Country
Italy
Authorized Representative
MEDRICH INSTRUMENT CO., LTD.
Product details
Intended Use
This product uses CLIA chemiluminescence immunoassay (CLIA) as a test reliability of the Leygo EBV shell antigen immunoglobulin M detection reagent in the Leysandr XL analyzer and the Leysandar XS analyzer.
Product Type (Level 1)
A Clinical chemistry and clinical toxicology
Product Type (Level 2)
A.1660 Quality control materials (analytical and non-analytical)
Import Information
Input;; QMS/QSD
Dates and status
Registration Date
Sep 22, 2023
Expiry Date
Sep 22, 2028
About this record

Access comprehensive regulatory information for Liyashang EBV Capsid Antigen IgM Detection Reagent - Quality Control Solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number eb99f1255a4c2c6e24641aeb7d9e94c7 and manufactured by DIASORIN ITALIA S.P.A.. The authorized representative in Taiwan is MEDRICH INSTRUMENT CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices